This website is intended for healthcare professionals

Acalabrutinib

Acalabrutinib in the management of chronic lymphocytic leukaemia

Many patients with CLL require surveillance only and have a normal life expectancy, with the majority of patients monitored with a watch and wait approach until the balance of risk and benefits...

Why choose Journal of Prescribing Practice?

Journal of Prescribing Practice shares the latest clinical expertise and professional guidance for non-medical prescribers. Our goal is to provide the knowledge to help you prescribe more efficiently and effectively.

What's included

  • Evidence-based best practice

  • Drug updates

  • Pharmacology information

  • Calculation skills

Subscriptions start:

From £16.25 GBP